Start reading instantly ,This title and over 12000 thousand more,available with Avenue Library, T&C*
Stroke Management Market by Type (Diagnostics, and Therapeutics) and by Application (Ischemic Stroke, and Haemorrhagic Stroke) - Global Opportunity Analysis and Industry Forecast, 2017-2023 Update Available On-Demand
| A00539 | Pages: 187 | Nov 2017 | 15763 Views | | |
| Author(s) : Onkar Sumant and Abha Thakur | Tables: 93 | Charts: 73 | Formats*: | |
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Stroke Management Market
Request Now !Stroke Management Market Overview:
The Global Stroke Management Market accounted for $22,581 million in 2016, and is estimated to reach $36,756 million by 2023, growing at a CAGR of 7.1% during the analysis period (2017-2023). Stroke is a medical emergency that occurs when the blood flow to the brain is interrupted and brain cells start to die.
Rise in incidence and prevalence of chronic diseases drives the market. In addition, growth of geriatric population that is susceptible to stroke, and patient increase incidences of diabetes and tobacco usage are driving the market during the analysis period. However, high cost of treatment and stringent government regulations for the approval of new and advances devices and drugs is anticipated to restrict the market growth.
Segment Review
Based on type, the global stroke management market is categorized into diagnostics and therapeutics. Diagnostics held the highest market share and is expected to grow with the highest growth rate during the forecast period. Increase in adoption of diagnosis process such as CT scan, MRI and others for the on time diagnosis of stroke is driving the market. On the basis of application, ischemic stroke held the highest market share owing to increase in prevalence of ischemic stroke and trauma cases.
Global Stroke Management Market, By Type
Get more information on this report : Request Sample Pages
Global Stroke Management Market, By Application
Get more information on this report : Request Sample Pages
Geographic Review
By geography, the global stroke management market is segmented into North America, Europe, Asia-Pacific, and LAMEA. North America held the largest share of the market in 2016, followed by Europe. On the other hand, Asia is anticipated to be the fastest-growing regional segment during the analysis period. The key factors that drive the growth of this market include increase in pool of patient population, growth in prevalence of stroke and chronic diseases, and rise in government investments for the development of better healthcare facilities and R&D. Asia-Pacific is expected to emerge as the area with maximum growth potential due to the focus of key players in the emerging economies and improvements in healthcare infrastructure.
Global Stroke Management Market, By Geography
Get more information on this report : Request Sample Pages
Market Drivers
Increasing Patient Awareness
Awareness among patients about stroke management plays a vital role in the growth of market. Several educational and awareness programs are initiated by government and key players in the market to increase the awareness level for the treatment of stroke among patients, doctors, and healthcare providers. For instance, a public health action plan to prevent heart disease and stroke by CDC provides a comprehensive strategy to combat heart failures that requires prevention, detection, and treatment of heart attacks and strokes. Medtronic India has also taken certain initiatives to train doctors about new technologies for better clinical outcomes. Moreover, many other government organizations such as Heart Foundation, American Heart Association, and World Health Organization have initiated several activities to increase awareness regarding the prevention and treatment of strokes.
Apart from this, Medtronic (India) initiated a new awareness program named Healthy Heart for All (HHFA) in September 2010. The aim of this initiative was to provide innovative and advanced therapies of cardiac care to everyone. This ensured that technologically advanced devices are available for treatment and reduced the burden of unmet medical needs of patients in developing countries. In addition, the American Heart Association has collaborated with the American Academy of Family Physicians, The Heart Rhythm Society, and The International Society for Heart & Lung Transplantation to provide guidelines that help to improve the health of patients.
Large Pool of Geriatric Population
Geriatric population are particularly vulnerable to stroke and need medication to maintain their health conditions. According to the Journal of American Medical Association, more than 40% of older population (55 age and above) of America are susceptible to stroke.
Major companies operating in this market adopt product launch as their key development strategy. Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corp., Bristol-Myers Squibb, Medtronic Plc., Cardinal Health, GE Healthcare, Siemens Healthcare, Glaxosmithkline Plc., and Merck & Company.
Other prominent players in the value chain include Mizuho America Inc., Koninklijke Philips N.V., Genentech Inc., Stryker Corporation, ZOLL Medical Corporation, and others
Key Benefits for Stakeholders
- The study provides an in-depth analysis of the stroke management market with current trends and future estimations to elucidate the imminent investment pockets
- The report provides a quantitative analysis from 2016 to 2023 to enable the stakeholders to capitalize on prevailing market opportunities
- Extensive analysis by product and application helps understand various trends and prevailing opportunities in the respective market
- Comprehensive analysis of all geographical regions is provided, which determines the main opportunities in these geographies
- Key market players are profiled and their strategies are analyzed thoroughly, which predict the competitive outlook of the market
Stroke Management Market Key Segments:
By Type
- Diagnostics
- Computed Tomography Scan (CT Scan)
- Magnetic Resonance Imaging (MRI)
- Carotid Ultrasound
- Cerebral Angiography
- Electrocardiography
- Echocardiography
- Others
- Therapeutics
- Tissue Plasminogen Activator
- Anticoagulant
- Antiplatelet
- Antihypertensive
By Application
- Ischemic Stroke
- Haemorrhagic Stroke
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. PORTERS FIVE FORCES ANALYSIS
3.3.1. Bargaining power of buyers
3.3.2. Bargaining power of suppliers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Competitive rivalry
3.4. TOP PLAYER POSITIONING, 2017
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.1.1. Growth in incidence of cardiac disorders
3.5.1.2. Increase in geriatric population
3.5.1.3. Rise in patient awareness
3.5.2. Restraints
3.5.2.1. Limited insurance coverage and high cost of devices
3.5.3. Opportunities
3.5.3.1. Improvement in healthcare infrastructure in emerging nations
CHAPTER 4 STROKE MANAGEMENT MARKET, BY TYPE
4.1. OVERVIEW
4.2. DIAGNOSTICS
4.2.1. Key market trends and opportunities
4.2.2. Market size and forecast
4.2.3. Computed tomography scan (CT Scan)
4.2.3.1. Market size and forecast
4.2.4. Magnetic resonance imaging (MRI)
4.2.4.1. Market size and forecast
4.2.5. Carotid ultrasound
4.2.5.1. Market size and forecast
4.2.6. Cerebral angiography
4.2.6.1. Market size and forecast
4.2.7. Electrocardiography
4.2.7.1. Market size and forecast
4.2.8. Echocardiography
4.2.8.1. Market size and forecast
4.2.9. Other diagnostics
4.2.9.1. Market size and forecast
4.3. THERAPEUTICS
4.3.1. Key market trends and opportunities
4.3.2. Market size and forecast
4.3.3. Tissue plasminogen activator
4.3.3.1. Market size and forecast
4.3.4. Anticoagulant
4.3.4.1. Market size and forecast
4.3.5. Antiplatelet
4.3.5.1. Market size and forecast
4.3.6. Antihypertensive
4.3.6.1. Market size and forecast
CHAPTER 5 STROKE MANAGEMENT MARKET, BY APPLICATION
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. ISCHEMIC STROKE
5.2.1. Market size and forecast
5.3. HEMORRHAGIC STROKE
5.3.1. Market size and forecast
CHAPTER 6 STROKE MANAGEMENT MARKET, BY REGION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NORTH AMERICA
6.2.1. Key market trends and opportunities
6.2.2. Market size and forecast
6.2.3. U.S. market size and forecast
6.2.4. Canada market size and forecast
6.2.5. Mexico market size and forecast
6.3. EUROPE
6.3.1. Key market trends and opportunities
6.3.2. Market size and forecast
6.3.3. Germany market size and forecast
6.3.4. France market size and forecast
6.3.5. UK market size and forecast
6.3.6. Italy market size and forecast
6.3.7. Spain market size and forecast
6.3.8. Rest of Europe market size and forecast
6.4. ASIA-PACIFIC
6.4.1. Key market trends and opportunities
6.4.2. Market size and forecast
6.4.3. Japan market size and forecast
6.4.4. China market size and forecast
6.4.5. Australia market size and forecast
6.4.6. India market size and forecast
6.4.7. South Korea market size and forecast
6.4.8. Taiwan market size and forecast
6.4.9. Rest of Asia-Pacific market size and forecast
6.5. LAMEA
6.5.1. Key market trends and opportunities
6.5.2. Market size and forecast
6.5.3. Brazil market size and forecast
6.5.4. Turkey market size and forecast
6.5.5. Saudi Arabia market size and forecast
6.5.6. South Africa market size and forecast
6.5.7. Rest of LAMEA market size and forecast
CHAPTER 7 COMPANY PROFILES
7.1. ABBOTT LABORATORIES
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. B. BRAUN MELSUNGEN AG
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.3. BOSTON SCIENTIFIC CORPORATION
7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments
7.4. BRISTOL-MYERS SQUIBB COMPANY
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments
7.5. CARDINAL HEALTH, INC.
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.6. GE HEALTHCARE (A HEALTHCARE DIVISION OF GE COMPANY)
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. GLAXOSMITHKLINE PLC
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.7.5. Business performance
7.8. MEDTRONIC PLC
7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments
7.9. MERCK & CO., INC.
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.10. SIEMENS AKTIENGESELLSCHAFT (SIEMENS HEALTHCARE)
7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 2. GLOBAL STROKE MANAGEMENT MARKET FOR DIAGNOSTICS, BY TYPE, 2016-2023 ($MILLION)
TABLE 3. STROKE MANAGEMENT MARKET FOR DIAGNOSTICS, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL STROKE MANAGEMENT MARKET FOR THERAPEUTICS, BY TYPE, 2016-2023 ($MILLION)
TABLE 5. STROKE MANAGEMENT MARKET FOR THERAPEUTICS, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 7. STROKE MANAGEMENT MARKET FOR ISCHEMIC STROKE, BY REGION, 2016-2023 ($MILLION)
TABLE 8. STROKE MANAGEMENT MARKET FOR HEMORRHAGIC STROKE, BY REGION, 2016-2023 ($MILLION)
TABLE 9. STROKE MANAGEMENT MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. NORTH AMERICA STROKE MANAGEMENT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 11. NORTH AMERICA STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 12. NORTH AMERICA STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 13. U.S. STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 14. U.S. STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 15. CANADA STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 16. CANADA STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 17. MEXICO STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 18. MEXICO STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 19. EUROPE STROKE MANAGEMENT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 20. EUROPE STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 21. EUROPE STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 22. GERMANY STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 23. GERMANY STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 24. FRANCE STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 25. FRANCE STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 26. UK STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 27. UK STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 28. ITALY STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 29. ITALY STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 30. SPAIN STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 31. SPAIN STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 32. REST OF EUROPE STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 33. REST OF EUROPE STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 34. ASIA-PACIFIC STROKE MANAGEMENT MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 35. ASIA-PACIFIC STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 36. ASIA-PACIFIC STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 37. JAPAN STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 38. JAPAN STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 39. CHINA STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 40. CHINA STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 41. AUSTRALIA STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 42. AUSTRALIASTROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 43. INDIA STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 44. INDIA STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 45. SOUTH KOREA STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 46. SOUTH KOREA STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 47. TAIWAN STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 48. TAIWAN STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 49. REST OF ASIA-PACIFIC STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 50. REST OF ASIA-PACIFIC STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 51. LAMEA STROKE MANAGEMENT MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 52. LAMEA STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 53. LAMEA STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 54. BRAZIL STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 55. BRAZIL STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 56. TURKEY STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 57. TURKEY STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 58. SAUDI ARABIA STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 59. SAUDI ARABIA STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 60. SOUTH AFRICA STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 61. SOUTH AFRICA STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 62. REST OF LAMEA STROKE MANAGEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)
TABLE 63. REST OF LAMEA STROKE MANAGEMENT MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 64. ABBOTT: COMPANY SNAPSHOT
TABLE 65. ABBOTT: OPERATING SEGMENTS
TABLE 66. ABBOTT: PRODUCT PORTFOLIO
TABLE 67. B BRAUN: COMPANY SNAPSHOT
TABLE 68. B BRAUN: OPERATING SEGMENTS
TABLE 69. B BRAUN: PRODUCT PORTFOLIO
TABLE 70. BOSTON SCIENTIFIC: COMPANY SNAPSHOT
TABLE 71. BOSTON SCIENTIFIC: OPERATING SEGMENTS
TABLE 72. BOSTON SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 73. BRISTOL-MYERS SQUIBB: COMPANY SNAPSHOT
TABLE 74. BRISTOL-MYERS SQUIBB: OPERATING SEGMENTS
TABLE 75. BRISTOL-MYERS SQUIBB: PRODUCT PORTFOLIO
TABLE 76. CARDINAL HEALTH: COMPANY SNAPSHOT
TABLE 77. CARDINAL HEALTH: OPERATING SEGMENTS
TABLE 78. CARDINAL HEALTH: PRODUCT PORTFOLIO
TABLE 79. GE HEALTHCARE: COMPANY SNAPSHOT
TABLE 80. GE HEALTHCARE: OPERATING SEGMENTS
TABLE 81. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 82. GSK: COMPANY SNAPSHOT
TABLE 83. GSK: OPERATING SEGMENTS
TABLE 84. GSK: PRODUCT PORTFOLIO
TABLE 85. MEDTRONIC: COMPANY SNAPSHOT
TABLE 86. MEDTRONIC: OPERATING SEGMENTS
TABLE 87. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 88. MERCK: COMPANY SNAPSHOT
TABLE 89. MERCK: OPERATING SEGMENTS
TABLE 90. MERCK: PRODUCT PORTFOLIO
TABLE 91. SIEMENS: COMPANY SNAPSHOT
TABLE 92. SIEMENS: OPERATING SEGMENTS
TABLE 93. SIEMENS: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 1. MARKET SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS
FIGURE 3. TOP WINNING STRATEGIES, 2014-2017 (%)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE, 2014-2017
FIGURE 5. TOP PLAYER POSITIONING: STROKE MANAGEMENT MARKET, 2017
FIGURE 6. POPULATION AGED 65 AND OVER BY REGION: 2015, 2030, AND 2050
FIGURE 7. STROKE MANAGEMENT MARKET FOR DIAGNOSTICS, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 8. GLOBAL DIAGNOSTICS STROKE MANAGEMENT MARKET FOR COMPUTED TOMOGRAPHY SCAN, 2016-2023 ($MILLION)
FIGURE 9. GLOBAL DIAGNOSTICS STROKE MANAGEMENT MARKET FOR MAGNETIC RESONANCE IMAGING (MRI), 2016-2023 ($MILLION)
FIGURE 10. GLOBAL DIAGNOSTICS STROKE MANAGEMENT MARKET FOR CAROTID ULTRASOUND, 2016-2023 ($MILLION)
FIGURE 11. GLOBAL DIAGNOSTICS STROKE MANAGEMENT MARKET FOR CEREBRAL ANGIOGRAPHY, 2016-2023 ($MILLION)
FIGURE 12. GLOBAL DIAGNOSTICS STROKE MANAGEMENT MARKET FOR ELECTROCARDIOGRAPHY, 2016-2023 ($MILLION)
FIGURE 13. GLOBAL DIAGNOSTICS STROKE MANAGEMENT MARKET FOR ECHOCARDIOGRAPHY, 2016-2023 ($MILLION)
FIGURE 14. GLOBAL DIAGNOSTICS STROKE MANAGEMENT MARKET FOR OTHER DIAGNOSTICS, 2016-2023 ($MILLION)
FIGURE 15. STROKE MANAGEMENT MARKET FOR THERAPEUTICS, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 16. GLOBAL THERAPEUTICS STROKE MANAGEMENT MARKET FOR TISSUE PLASMINOGEN ACTIVATOR, 2016-2023 ($MILLION)
FIGURE 17. GLOBAL THERAPEUTICS STROKE MANAGEMENT MARKET FOR ANTICOAGULANT, 2016-2023 ($MILLION)
FIGURE 18. GLOBAL THERAPEUTICS STROKE MANAGEMENT MARKET FOR ANTIPLATELET, 2016-2023 ($MILLION)
FIGURE 19. GLOBAL THERAPEUTICS STROKE MANAGEMENT MARKET FOR ANTIHYPERTENSIVE, 2016-2023 ($MILLION)
FIGURE 20. STROKE MANAGEMENT MARKET FOR ISCHEMIC STROKE, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 21. STROKE MANAGEMENT MARKET FOR HEMORRHAGIC STROKE, BY COUNTRY, 2016-2023 ($MILLION)
FIGURE 22. GENERAL GOVERNMENT EXPENDITURE ON HEALTH AS A PERCENTAGE OF TOTAL GOVERNMENT EXPENDITURE
FIGURE 23. U.S. STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 24. CANADA STROKE MANAGEMENT MARKET, 2016-2023 $MILLION)
FIGURE 25. MEXICO STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 26. GERMANY STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 27. FRANCE STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 28. UK STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 29. ITALY STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 30. SPAIN STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 31. REST OF EUROPE STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 32. GDP OF ASIAN COUNTRIES ($BILLION)
FIGURE 33. JAPAN STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 34. CHINA STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 35. AUSTRALIA STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 36. INDIA STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 37. SOUTH KOREA STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 38. TAIWAN STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 39. REST OF ASIA-PACIFIC STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 40. BRAZIL STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 41. TURKEY STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 42. SAUDI ARABIA STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 43. SOUTH AFRICA STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 44. REST OF LAMEA STROKE MANAGEMENT MARKET, 2016-2023 ($MILLION)
FIGURE 45. ABBOTT: NET SALES, 2014-2016 ($MILLION)
FIGURE 46. ABBOTT: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 47. ABBOTT: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 48. B BRAUN: NET SALES, 2014-2016 ($MILLION)
FIGURE 49. B BRAUN: REVENUE SHARE BY PRODUCT, 2016 (%)
FIGURE 50. B BRAUN: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 51. BOSTON SCIENTIFIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 52. BOSTON SCIENTIFIC: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 53. BOSTON SCIENTIFIC: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 54. BRISTOL-MYERS SQUIBB: NET SALES, 2014-2016 ($MILLION)
FIGURE 55. BRISTOL-MYERS SQUIBB: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 56. BRISTOL-MYERS SQUIBB: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 57. CARDINAL HEALTH: NET SALES, 2014-2016 ($MILLION)
FIGURE 58. CARDINAL HEALTH: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 59. GE HEALTHCARE: NET SALES, 2014-2016 ($MILLION)
FIGURE 60. GE HEALTHCARE: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 61. GE HEALTHCARE: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 62. GSK: NET SALES, 2014-2016 ($MILLION)
FIGURE 63. GSK: REVENUE SHARE BY SHARE, 2016 (%)
FIGURE 64. GSK: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 65. MEDTRONIC: NET SALES, 2014-2016 ($MILLION)
FIGURE 66. MEDTRONIC: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 67. MEDTRONIC: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 68. MERCK: NET SALES, 2014-2016 ($MILLION)
FIGURE 69. MERCK: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 70. MERCK: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
FIGURE 71. SIEMENS: NET SALES, 2014-2016 ($MILLION)
FIGURE 72. SIEMENS: REVENUE SHARE BY SEGMENT, 2016 (%)
FIGURE 73. SIEMENS: REVENUE SHARE BY GEOGRAPHY, 2016 (%)
The stroke management market has witnessed significant changes with technologies exemplifying the recent and unique advancements in the field of medical devices and strengthened the effectiveness of treatment for the stroke diagnostics and treatment. Moreover, high susceptibility of the geriatric population to various disorders and rising demand for diagnostics has boosted the stroke management market. This report provides a detailed analysis of the global stroke management market, including market estimates and trends through 2023. It covers the stroke management market segmented on the basis of type, application, and region. The different types of stroke managements included in this report are diagnostics and therapeutics.
North America accounted for the highest share owing to increase in demand for advanced medical technologies and rise in investment in healthcare. In addition, significant investments in healthcare R&D in North America are anticipated to create new opportunities for the market growth during the analysis period. Asia-Pacific accounted for the highest market potential owing to rise in prevalence of strokes owing to high incidence of chronic diseases and tobacco usage. In addition, government initiatives for the improvement of healthcare sector, and rise in focus of leading manufacturers to expand their geographical presence in the emerging economy regions are expected to gain high growth opportunities in the market.
Major companies involved in the stroke management market are Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corp., Bristol-Myers Squibb, Medtronic Plc., Cardinal Health, GE Healthcare, Siemens Healthcare, Glaxosmithkline Plc., and Merck & Company
Access from any device, anywhere
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Download Sample
Purchase Full Report of
Stroke Management Market- Global Opportunity Analysis and Industry Forecast, 2017-2023
- Online Only
- $3,456
- Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
- $3,840
- Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
- $5,769
- Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
- $6,450
- Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF - $8,995
- Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $ 699/mo
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading instantly.
Buy Now
This title and over 12,000+ are available on the Avenue Library. T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers